Sinocare iCan i3 - Page 80

User Guide CGM
77 Attachment D Technical Information
Performance Metrics* Result Notes
Clinical Accuracy 100% % of readings in Consensus Error Grid Zone A (%
CEG Zone A+B)
Glucose readings in zones A and B are considered
to be clinically acceptable, whereas results outside of
zones A and B may have a negative clinical outcome.
Higher numbers are better.
*Reference is venous plasma glucose value measured on YSI glucose
analyzer (Yellow Springs Laboratory Instrument)
Potential Clinical benets
Some potential benets of using your iCan i3 CGM System are
• Improved management of glycemic control
■ Improved management of HbA1c/A1c value (denoting
improvement of glycaemic control)
■ Reduced events of severe hypoglycemia in hypoglycemia
unawareness
■ Reduced events and duration of hyperglycemia
• Potential for increased self-management
■ Increased patient insight regarding food, portions, physical activity,
stress, diabetes medication choices
■ Increased proactive and retroactive decision-making by patients
as a result of easy and timely access to more data, including post-
prandial and overnight data.
■ Increased ability and speed to self-assess validity of management
changes which can increase sense of empowerment and self-
e󰀩cacy
■ Increased types of glycemic metrics available (% time in range,
etc)